Skip to main content
Ackermans & van Haaren NV logo

Ackermans & van Haaren NV — Investor Relations & Filings

Ticker · ACKB ISIN · BE0003764785 LEI · 5493005E2GHATS0Z6J59 BR Financial and insurance activities
Open in API
Filings indexed 2,094 across all filing types
Latest filing 2024-07-26 Capital/Financing Update
Country BE Belgium
Listing BR ACKB

About Ackermans & van Haaren NV

https://www.avh.be/en

Ackermans & van Haaren is an independent and diversified investment group focused on creating long-term shareholder value. The company acts as a strategic partner for a limited number of businesses with international growth potential, aiming to build high-performing market leaders. Its core investment segments include Marine Engineering & Contracting, Private Banking, Real Estate & Senior Care, Energy & Resources, and Growth Capital. The Marine Engineering & Contracting division is a significant player in global dredging, offshore wind farm installation, and green hydrogen development. The group emphasizes sustainable growth in its partnerships with family businesses and management teams.

Recent filings

Filing Released Lang Actions
25904-V2 20240726_PPR_AvH invests in Confo_FR.pdf
Capital/Financing Update Classification · 98% confidence The document is a press release dated July 26, 2024, announcing that Ackermans & van Haaren (AvH) is leading a 60 million euro Series B funding round for Confo Therapeutics. The text explicitly details the investment commitment, the use of funds (clinical trials), and quotes from management. This type of announcement, focusing on fundraising, financing activities, and capital structure changes, directly aligns with the definition of 'Capital/Financing Update'. The document is not a full annual report (10-K), an earnings release (ER), or a simple announcement of a report publication (RPA).
2024-07-26 French
20240726_PPR_AvH invests in Confo_NL.pdf
Share Issue/Capital Change Classification · 99% confidence The document is a press release dated July 26, 2024, announcing that Ackermans & van Haaren (AvH) is leading a EUR 60 million Series B financing round for Confo Therapeutics. This type of announcement details a significant corporate financing activity, specifically equity fundraising. This aligns directly with the definition of 'Capital/Financing Update' (CAP). It is not an Annual Report (10-K), an Earnings Release (ER), or a general Regulatory Filing (RNS), as it describes a specific capital event.
2024-07-26 Dutch
20240724_AvH inkoop vervreemding eigen aandelen UK.pdf
Transaction in Own Shares Classification · 100% confidence The document is explicitly titled "ACQUISITION AND DISPOSAL OF OWN SHARES" and details the number of shares bought and sold by the company (Ackermans & van Haaren NV) within a specific period (July 15, 2024, to July 24, 2024), including transaction prices and totals. This directly corresponds to the definition of a report concerning the company buying back or selling its own shares. This matches the 'Transaction in Own Shares' category (POS). The document is a detailed report, not just an announcement of a report, and its length (6322 chars) suggests it is the primary disclosure.
2024-07-24 English
20240724_AvH inkoop vervreemding eingen aandelen FR.pdf
Transaction in Own Shares Classification · 100% confidence The document is titled "RACHAT ET ALIÉNATION D'ACTIONS PROPRES" (Repurchase and Alienation of Own Shares) and details transactions (purchases and sales) of the company's own stock conducted under a liquidity program between July 15, 2024, and July 24, 2024. This activity directly relates to the company managing its own share capital by buying back or selling treasury shares. This aligns precisely with the definition for 'Transaction in Own Shares' (Code: POS). It is not a general earnings release (ER), an annual report (10-K), or a management discussion (MDA), but a specific report on share transactions.
2024-07-24 French
20240724_AvH inkoop vervreemding eigen aandelen NL.pdf
Transaction in Own Shares Classification · 100% confidence The document title is "INKOOP EN VERVREEMDING EIGEN AANDELEN" (Purchase and Disposal of Own Shares). The content details transactions (purchases and sales) of the company's own shares conducted under a liquidity agreement between July 15, 2024, and July 24, 2024. This directly corresponds to the definition of a report concerning the company buying back or selling its own shares. This matches the 'Transaction in Own Shares' category (POS). It is not a general regulatory filing (RNS) because it is highly specific, nor is it a proxy statement (DEF 14A) or an earnings release (ER).
2024-07-24 Dutch
20240715_AvH inkoop vervreemding eigen aandelen UK.pdf
Transaction in Own Shares Classification · 100% confidence The document is explicitly titled "ACQUISITION AND DISPOSAL OF OWN SHARES" and provides detailed tables showing the number of shares acquired and disposed of by the company (Ackermans & van Haaren NV) on specific dates (July 4 to July 13, 2024) under a liquidity program. This activity directly corresponds to the definition of a company buying back or selling its own shares, which maps precisely to the 'Transaction in Own Shares' category. Code mapping: Transaction in Own Shares -> POS.
2024-07-15 English

Browse filings by year

16 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.